Mark Moehle
ASO PROF
MD-PHARMACOLOGY - THERAPEUTICS
GRANTS
- GRANTExploration of Compounds that Modulate Protein Phosphatase 2A to Treat Parkinson’s DiseaseParkinsons Foundation25 Jun 2026 - 31 Jul 2028
- GRANTStriatal Mu Opioid Receptor Containing Neurons in L-DOPA induced dyskinesiaNational Institute of Health Ninds5 May 2026 - 30 Apr 2028
- GRANTHuman alpha-synuclein templated pathology disruption of M2 cortex to striatum synaptic transmission and motor behaviors in Parkinson’s diseaseFox Foundation, Michael J2 Jun 2023 - 31 Dec 2025
- GRANTCholinergic Mechanisms in Lewy Body DementiaNational Institute of Health Ninds31 Mar 2023 - 31 Mar 2028
- GRANTPathophysiology of DYT1 dystonia: Targeted Mouse ModelsNational Institute of Health Ninds27 Sep 2022 - 31 Aug 2027
- GRANTM5 modulators to treat or modify the motor symptoms of Parkinson’s DiseaseFox Foundation, Michael J18 Jul 2022 - 29 Nov 2024
- GRANTM4 muscarinic acetylcholine receptor signaling as a potent regulator of motor deficitsNational Institute of Health Ninds9 Mar 2021 - 29 Feb 2024
- GRANTImpact of aggregated a-synuclein on altering neuronal physiology and plasticity in vivo and ex vivo in relevant animal models of LBDUF Foundation22 Dec 2020 - 31 Dec 2021
- GRANTMolecular Mechanisms of Hair Bundle Development and MaintenanceNational Institute of Health Nidcd29 Jun 2020 - 5 May 2026
- GRANTNational Institute of Neurological Disorders and Stroke1 Apr 2019 - 31 Aug 2020People funded by this grant:
- MOEHLE MS
- GRANTNational Institute of Neurological Disorders and Stroke28 Sep 2012 - 31 May 2015People funded by this grant:
- MOEHLE MS
